Nordson said sales for the July 31 ended Q3 were $742 million, up from $662 million in the prior year period, and diluted earnings per share were $2.22, compared to $2.04 in the prior year period.

1. 01

   Nordson said sales for the July 31 ended Q3 were $742 million, up from $662 million in the prior year period, and diluted earnings per share were $2.22, compared to $2.04 in the prior year period.

2. 02

   The company said adjusted diluted earnings per share for Q3 were $2.73, up 13% from $2.41 in the prior year period, and EBITDA was $239 million, or 32% of sales, compared to $208 million, or 31% of sales, in the prior year period.

3. 03

   Nordson said organic sales for Q3 increased 15% in Advanced Technology Solutions and decreased 2% in Industrial Precision Solutions. Medical and Fluid Solutions sales increased 32%, which included an acquisition impact of 31%, while organic sales were flat.

4. 04

   The company said the Board of Directors authorized on August 18, 2025 the repurchase of an additional $500 million of the company's common shares. When added to the approximate $293 million remaining from previously approved Board share repurchase authorizations, the total share repurchase authorization is approximately $793 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.